Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain
- PMID: 15572168
- DOI: 10.1016/j.brainresrev.2004.05.002
Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain
Abstract
Dopaminergic nigrostriatal neurons may be considered as bipolar functional entities since they are endowed with the ability to synthesize, store and release the transmitter dopamine (DA) at the somatodendritic level in the substantia nigra (SN). Such dendritic DA release seems to be distinct from the transmitter release occurring at the axon terminal and seems to rely preferentially on volume transmission to exert its physiological effects. An increased glutamatergic (Gluergic) transmission into the SN facilitates such dendritic DA release via activation of NMDA-receptors (NMDA-Rs) and to a lesser extent through group II metabotropic glutamate receptors (mGluRs). In addition, nigral mGluRs functionally interact with NMDA-Rs in the SN, further modulating the NMDA-R-mediated increase of DA release from dendrites in the SN. In turn, dendritically released DA may exert, via D1 receptors, a tonic inhibitory control upon nigral glutamate (Glu). Furthermore, released DA, via D2/D3 autoreceptors, produces an autoinhibitory effect upon DA cell firing and its own release process. An increased Gluergic transmission into the SN may also induce, via activation of NMDA-Rs, an augmented expression of different brain-derived neurotrophic factor (BDNF) gene transcripts in this brain area. Pharmacological evidence suggests that non-NMDA-Rs could also participate in the regulation of BDNF gene expression in the SN. Glu-mediated changes of nigral BDNF expression could regulate, in turn, the expression of important transmitter-related proteins in the SN, such as different NMDA-R subunits, mGluRs and DA-D3 receptors. In conclusion, Glu-DA-BDNF interactions in the SN may play an important role in modulating the flow of neuronal information in this brain structure under normal conditions, as well as during adaptive and plastic responses associated with various neurological and psychiatric disorders.
Similar articles
-
NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.J Neurosci Res. 2009 Aug 1;87(10):2308-18. doi: 10.1002/jnr.22063. J Neurosci Res. 2009. PMID: 19326433
-
Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.Exp Neurol. 2008 Jul;212(1):63-70. doi: 10.1016/j.expneurol.2008.03.001. Epub 2008 Mar 16. Exp Neurol. 2008. PMID: 18452916
-
Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release.J Neurochem. 2006 Feb;96(3):645-55. doi: 10.1111/j.1471-4159.2005.03519.x. Epub 2006 Jan 9. J Neurochem. 2006. PMID: 16405515
-
Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease.Amino Acids. 2007 Feb;32(2):189-95. doi: 10.1007/s00726-006-0320-3. Epub 2006 May 22. Amino Acids. 2007. PMID: 16715415 Review.
-
Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.Int Rev Neurobiol. 2007;78:377-95. doi: 10.1016/S0074-7742(06)78012-6. Int Rev Neurobiol. 2007. PMID: 17349867 Review.
Cited by
-
Novel alternative splicing predicts a truncated isoform of the NMDA receptor subunit 1 (NR1) in embryonic rat brain.Neurochem Res. 2005 Apr;30(4):567-76. doi: 10.1007/s11064-005-2691-3. Neurochem Res. 2005. PMID: 16076026
-
Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease.CNS Neurosci Ther. 2008 Winter;14(4):340-51. doi: 10.1111/j.1755-5949.2008.00058.x. CNS Neurosci Ther. 2008. PMID: 19040557 Free PMC article. Review.
-
An NR2B-Dependent Decrease in the Expression of trkB Receptors Precedes the Disappearance of Dopaminergic Cells in Substantia Nigra in a Rat Model of Presymptomatic Parkinson's Disease.Parkinsons Dis. 2012;2012:129605. doi: 10.1155/2012/129605. Epub 2012 Jun 7. Parkinsons Dis. 2012. PMID: 22720191 Free PMC article.
-
Sex-dependent impacts of low-level lead exposure and prenatal stress on impulsive choice behavior and associated biochemical and neurochemical manifestations.Neurotoxicology. 2014 Sep;44:169-83. doi: 10.1016/j.neuro.2014.06.013. Epub 2014 Jul 7. Neurotoxicology. 2014. PMID: 25010656 Free PMC article.
-
Nesfatin-1: a novel inhibitory regulator of food intake and body weight.Obes Rev. 2011 Apr;12(4):261-71. doi: 10.1111/j.1467-789X.2010.00770.x. Obes Rev. 2011. PMID: 20546141 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources